Clinical Trial of Dipyridamole in Schizophrenia

Completed · Not applicable

Conditions studied: Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder

In brief

This is a 6-week, randomized, double blind, parallel groups designed, olanzapine-controlled trial of oral dipyridamole in symptomatic patients with a (DSM IV) diagnosis of schizophrenia, schizoaffective or schizophreniform disorder. This pilot study aims to provide preliminary estimates of whether the effect sizes of dipyridamole on positive symptoms, negative symptoms, and cognitive deficits differ between schizophrenia patients treated with dipyridamole, and schizophrenia patients treated with olanzapine. A total of 30 subjects will be recruited locally.

Key facts

Study ID
NCT00349973
Run by
University of Maryland, Baltimore
People needed
29
Starts
2001-05-01
Expected to finish
2011-09-01
Last updated by the study team
2019-11-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.